What to Expect at the 5th Lipid Nanoparticles Development Summit Europe?
Expect a dynamic, forward-looking event focused on solving the biggest challenges in LNP development. From achieving precise, extrahepatic targeting to improving safety, scalability and real-world delivery, you’ll gain practical insights from leaders across biotech, pharma and academia.
Engage in interactive debates, hands-on discussions and real-world case studies designed to move beyond theory and into application. Whether you’re optimising formulation, advancing toward the clinic, or exploring next-generation delivery systems, this summit offers the clarity, connections and strategies needed to accelerate progress.
Unmissable Event Highlights
Debate: Breaking Liver Tropism
Hear leading experts go head-to-head on whether lipid chemistry, formulation tuning or active targeting will finally unlock clinically viable extrahepatic delivery.
End-to-End Simulation: From Concept to Clinic
Step through a real-world LNP development journey, making key decisions across design, CMC and regulatory strategy to understand where programs succeed, or fail.
Tackling Toxicity & Repeat Dosing Head-On
Explore the reality of LNP-induced immune responses, anti-PEG challenges and strategies to enable safer, repeatable dosing in therapeutic settings.
Next-Generation Targeting Beyond the Liver
Discover cutting-edge approaches to BBB penetration, cell-specific delivery and inhalation-based LNPs designed to reach previously inaccessible tissues.
Inside LNP Design & Intracellular Behaviour
Gain rare insight into how LNPs behave inside cells using advanced imaging and how this translates into improved delivery efficiency.
What’s New for 2026?
Stronger Focus on Clinical Translation
Greater emphasis on linking LNP design decisions to clinical outcomes, regulatory expectations and commercial viability.
New Debate & Simulation Sessions
Interactive formats including a live debate on breaking liver tropism and an end-to-end clinical simulation exercise.
Expanded Coverage of Toxicity & Repeat Dosing
Dedicated sessions addressing safety, immunogenicity and durability – topics often underrepresented but critical to success.
Introduction of End-User Perspectives
New session highlighting how researchers are applying LNPs in real therapeutic settings and where current systems fall short.
More Global & Diverse Speaker Faculty
Increased representation from emerging biotechs, international academia and cross-functional experts.
Attending Companies Include